Real world study of efficacy and adherence to subcutaneous vs. intravenous vedolizumab in patients with inflammatory bowel disease using a novel remote MONITORing intervention (MONITOR Study)

Go Back to All Clinical Trials

Real world study of efficacy and adherence to subcutaneous vs. intravenous vedolizumab in patients with inflammatory bowel disease using a novel remote MONITORing intervention (MONITOR Study)

Brief description of study

The purpose of the study is to assess the effectiveness of a remote monitoring system called Tappt. The study will investigate adherence to medical treatment, clinical outcomes (symptoms, quality of life, and mental health), and health care use.

Clinical Study Identifier: s24-01892

ClinicalTrials.gov Identifier: NCT06750731

Principal Investigator: Jordan E Axelrad.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Simon J Hong, Ariela Holmer, Lindsay Clarke, David P Hudesman, Bradley M. Morganstern.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies